Постановление Правительства Республики Тыва от 30.04.2013 № 250

|        | госпитализированных в    |                          |       |       |       |       |       |       |       |       |       |       |
|        | течение года             |                          |       |       |       |       |       |       |       |       |       |       |
+--------+--------------------------+--------------------------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+
| 1.24.  | Доля больных             |         процент          |  41   |  51   | 50,8  | 50,5  |  50   | 49,8  | 49,5  |  49   |  48   |  47   |
|        | наркоманиями, повторно   |                          |       |       |       |       |       |       |       |       |       |       |
|        | госпитализированных в    |                          |       |       |       |       |       |       |       |       |       |       |
|        | течение года             |                          |       |       |       |       |       |       |       |       |       |       |
+--------+--------------------------+--------------------------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+
| 1.25.  | Удовлетворение           |         процент          |  67   | 72,6  |  75   |  80   |  85   |  90   |  95   |  100  |  100  |  100  |
|        | потребности отдельных    |                          |       |       |       |       |       |       |       |       |       |       |
|        | категорий граждан в      |                          |       |       |       |       |       |       |       |       |       |       |
|        | необходимых              |                          |       |       |       |       |       |       |       |       |       |       |
|        | лекарственных препаратах |                          |       |       |       |       |       |       |       |       |       |       |
|        | и медицинских изделиях,  |                          |       |       |       |       |       |       |       |       |       |       |
|        | а также                  |                          |       |       |       |       |       |       |       |       |       |       |
|        | специализированных       |                          |       |       |       |       |       |       |       |       |       |       |
|        | продуктов лечебного      |                          |       |       |       |       |       |       |       |       |       |       |
|        | питания для              |                          |       |       |       |       |       |       |       |       |       |       |
|        | детей-инвалидов (от      |                          |       |       |       |       |       |       |       |       |       |       |
|        | числа лиц, имеющих право |                          |       |       |       |       |       |       |       |       |       |       |
|        | на государственную       |                          |       |       |       |       |       |       |       |       |       |       |
|        | социальную помощь и не   |                          |       |       |       |       |       |       |       |       |       |       |
|        | отказавшихся от          |                          |       |       |       |       |       |       |       |       |       |       |
|        | получения социальной     |                          |       |       |       |       |       |       |       |       |       |       |
|        | услуги, лекарственными   |                          |       |       |       |       |       |       |       |       |       |       |
|        | препаратами, изделия     |                          |       |       |       |       |       |       |       |       |       |       |
|        | медицинского назначения, |                          |       |       |       |       |       |       |       |       |       |       |
|        | а также                  |                          |       |       |       |       |       |       |       |       |       |       |
|        | специализированными      |                          |       |       |       |       |       |       |       |       |       |       |
|        | продуктами лечебного     |                          |       |       |       |       |       |       |       |       |       |       |
|        | питания для              |                          |       |       |       |       |       |       |       |       |       |       |
|        | детей-инвалидов )        |                          |       |       |       |       |       |       |       |       |       |       |
+--------+--------------------------+--------------------------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+
| 1.26.  | Удовлетворение спроса на |         процент          |  100  |  100  |  100  |  100  |  100  |  100  |  100  |  100  |  100  |  100  |
|        | лекарственные препараты, |                          |       |       |       |       |       |       |       |       |       |       |
|        | предназначенные для      |                          |       |       |       |       |       |       |       |       |       |       |
|        | лечения больных          |                          |       |       |       |       |       |       |       |       |       |       |
|        | злокачественными         |                          |       |       |       |       |       |       |       |       |       |       |
|        | новообразованиями        |                          |       |       |       |       |       |       |       |       |       |       |
|        | лимфоидной, кроветворной |                          |       |       |       |       |       |       |       |       |       |       |
|        | и родственных им тканей, |                          |       |       |       |       |       |       |       |       |       |       |
|        | гемофилией,              |                          |       |       |       |       |       |       |       |       |       |       |
|        | муковисцидозом,          |                          |       |       |       |       |       |       |       |       |       |       |
|        | гипофизарным нанизмом,   |                          |       |       |       |       |       |       |       |       |       |       |
|        | болезнью Гоше,           |                          |       |       |       |       |       |       |       |       |       |       |
|        | рассеянным склерозом, а  |                          |       |       |       |       |       |       |       |       |       |       |
|        | также трансплантации     |                          |       |       |       |       |       |       |       |       |       |       |
|        | органов и (или) тканей   |                          |       |       |       |       |       |       |       |       |       |       |
|        | (от числа лиц,           |                          |       |       |       |       |       |       |       |       |       |       |
|        | включенных в федеральный |                          |       |       |       |       |       |       |       |       |       |       |
|        | регистр больных и        |                          |       |       |       |       |       |       |       |       |       |       |
|        | больных злокачественными |                          |       |       |       |       |       |       |       |       |       |       |
|        | новообразованиями        |                          |       |       |       |       |       |       |       |       |       |       |
|        | лимфоидной, кроветворной |                          |       |       |       |       |       |       |       |       |       |       |
|        | и родственных им тканей, |                          |       |       |       |       |       |       |       |       |       |       |
|        | гемофилией,              |                          |       |       |       |       |       |       |       |       |       |       |
|        | муковисцидозом,          |                          |       |       |       |       |       |       |       |       |       |       |
|        | гипофизарным нанизмом,   |                          |       |       |       |       |       |       |       |       |       |       |
|        | болезнью Гоше,           |                          |       |       |       |       |       |       |       |       |       |       |
|        | рассеянным склерозом, а  |                          |       |       |       |       |       |       |       |       |       |       |
|        | также трансплантации     |                          |       |       |       |       |       |       |       |       |       |       |
|        | органов и (или) тканей)  |                          |       |       |       |       |       |       |       |       |       |       |
+--------+--------------------------+--------------------------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+
| 1.27.  | Смертность от            |   на 100 тыс.насления    | 60,2  | 58,1  | 57,8  | 57,5  | 57,2  | 56,9  | 56,6  | 56,3  |  56   | 55,7  |
|        | самоубийств              |                          |       |       |       |       |       |       |       |       |       |       |
+--------+--------------------------+--------------------------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+
|  Подпрограмма 2. Совершенствование оказания специализированной, включая высокотехнологичную, медицинской помощи, скорой, в том числе скорой   
|                                        специализированной, медицинской помощи, медицинской эвакуации                                          
+--------+--------------------------+--------------------------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+
|  2.1.  | Доля абацилированных     |         процент          | 26,1  | 22,1  |  27   |  28   | 28,5  | 29,5  | 31,5  | 32,5  | 33,5  |  35   |
|        | больных туберкулезом от  |                          |       |       |       |       |       |       |       |       |       |       |
|        | числа больных            |                          |       |       |       |       |       |       |       |       |       |       |
|        | туберкулезом с           |                          |       |       |       |       |       |       |       |       |       |       |
|        | бактериовыделением       |                          |       |       |       |       |       |       |       |       |       |       |
+--------+--------------------------+--------------------------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+
|  2.2.  | Доля ВИЧ-инфицированных  |         процент          |  23   | 23,2  | 24,1  | 24,8  | 25,2  | 25,2  |  26   | 26,8  | 27,5  |  28   |
|        | лиц, получающих          |                          |       |       |       |       |       |       |       |       |       |       |
|        | антиретровирусную        |                          |       |       |       |       |       |       |       |       |       |       |
|        | терапию, от числа        |                          |       |       |       |       |       |       |       |       |       |       |
|        | состоящих на             |                          |       |       |       |       |       |       |       |       |       |       |
|        | диспансерном учете       |                          |       |       |       |       |       |       |       |       |       |       |
+--------+--------------------------+--------------------------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+
|  2.3.  | Ожидаемая                |           лет            |  11   |  11   |  11   |  12   |  13   |  14   |  14   |  15   |  16   |  16   |
|        | продолжительность жизни  |                          |       |       |       |       |       |       |       |       |       |       |
|        | ВИЧ-инфицированных лиц,  |                          |       |       |       |       |       |       |       |       |       |       |
|        | получающих               |                          |       |       |       |       |       |       |       |       |       |       |
|        | антиретровирусную        |                          |       |       |       |       |       |       |       |       |       |       |
|        | терапию в соответствии с |                          |       |       |       |       |       |       |       |       |       |       |
|        | действующими стандартами |                          |       |       |       |       |       |       |       |       |       |       |
+--------+--------------------------+--------------------------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+
|  2.4.  | Число наркологических    |  Число наркологических   | 8,71  | 5,46  | 5,48  |  5,5  |  5,6  |  5,7  |  5,8  |  5,9  | 5,95  |   6   |
|        | больных, находящихся в   |  больных, находящихся в  |       |       |       |       |       |       |       |       |       |       |
|        | ремиссии от 1 года до 2  |     ремиссии на 100      |       |       |       |       |       |       |       |       |       |       |
|        | лет                      | наркологических больных  |       |       |       |       |       |       |       |       |       |       |
|        |                          |      среднегодового      |       |       |       |       |       |       |       |       |       |       |
|        |                          |       контингента        |       |       |       |       |       |       |       |       |       |       |
+--------+--------------------------+--------------------------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+
|  2.5.  | Число наркологических    |  Число наркологических   | 7,28  | 4,88  |  4,9  | 4,95  |   5   | 5,05  |  5,1  | 5,15  |  5,2  | 5,25  |
|        | больных, находящихся в   |  больных, находящихся в  |       |       |       |       |       |       |       |       |       |       |
|        | ремиссии более 2 лет     |     ремиссии на 100      |       |       |       |       |       |       |       |       |       |       |
|        |                          | наркологических больных  |       |       |       |       |       |       |       |       |       |       |
|        |                          |      среднегодового      |       |       |       |       |       |       |       |       |       |       |
|        |                          |       контингента        |       |       |       |       |       |       |       |       |       |       |
+--------+--------------------------+--------------------------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+
|  2.6.  | Число больных            |      Число больных       |  7,3  |  4,2  |  4,5  |  4,8  |   5   |  5,2  |  5,5  |  5,8  |   6   |  6,2  |
|        | алкоголизмом,            |      алкоголизмом,       |       |       |       |       |       |       |       |       |       |       |
|        | находящихся в ремиссии   |  находящихся в ремиссии  |       |       |       |       |       |       |       |       |       |       |
|        | более от 1 до 2 лет      |  на 100 наркологических  |       |       |       |       |       |       |       |       |       |       |
|        |                          |  больных среднегодового  |       |       |       |       |       |       |       |       |       |       |
|        |                          |       контингента        |       |       |       |       |       |       |       |       |       |       |
+--------+--------------------------+--------------------------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+
|  2.7.  | Число больных            |      Число больных       |  6,4  |  3,5  |  3,8  |   4   |  4,2  |  4,5  |  4,8  |   5   |  5,2  |  5,5  |
|        | алкоголизмом,            |      алкоголизмом,       |       |       |       |       |       |       |       |       |       |       |
|        | находящихся в ремиссии   |  находящихся в ремиссии  |       |       |       |       |       |       |       |       |       |       |
|        | более 2 лет              |  на 100 наркологических  |       |       |       |       |       |       |       |       |       |       |
|        |                          |  больных среднегодового  |       |       |       |       |       |       |       |       |       |       |
|        |                          |       контингента        |       |       |       |       |       |       |       |       |       |       |
+--------+--------------------------+--------------------------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+
|  2.8.  | Доля больных             |         Процент          | 18,9  | 21,5  |  21   |  20   | 19,8  | 19,5  |  19   | 18,8  | 18,5  |  18   |
|        | психическими             |                          |       |       |       |       |       |       |       |       |       |       |
|        | расстройствами повторно  |                          |       |       |       |       |       |       |       |       |       |       |
|        | госпитализированных в    |                          |       |       |       |       |       |       |       |       |       |       |
|        | течение года             |                          |       |       |       |       |       |       |       |       |       |       |
+--------+--------------------------+--------------------------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+
|  2.9.  | Смертность от            |  на 100 тыс. населения   | 205,4 | 223,9 | 223,7 | 223,5 | 223,3 | 223,1 | 222,9 | 222,7 | 222,5 | 222,3 |
|        | ишемической болезни      |                          |       |       |       |       |       |       |       |       |       |       |
|        | сердца                   |                          |       |       |       |       |       |       |       |       |       |       |
+--------+--------------------------+--------------------------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+
| 2.10.  | Смертность от            |  на 100 тыс. населения   | 123,1 | 121,3 | 121,1 | 120,9 | 120,7 | 120,5 | 120,3 | 120,1 | 119,9 | 119,7 |
|        | цереброваскулярных       |                          |       |       |       |       |       |       |       |       |       |       |
|        | заболеваний              |                          |       |       |       |       |       |       |       |       |       |       |
+--------+--------------------------+--------------------------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+
| 2.11.  | Удельный вес больных     |         процент          | 43,5  | 46,6  |  47   | 47,5  |  48   | 48,5  |  49   | 49,5  |  50   | 55,5  |
|        | злокачественными         |                          |       |       |       |       |       |       |       |       |       |       |
|        | новообразованиями,       |                          |       |       |       |       |       |       |       |       |       |       |
|        | состоящих на учете с     |                          |       |       |       |       |       |       |       |       |       |       |
|        | момента установления     |                          |       |       |       |       |       |       |       |       |       |       |
|        | диагноза 5 лет и более   |                          |       |       |       |       |       |       |       |       |       |       |
+--------+--------------------------+--------------------------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+
| 2.12.  | Одногодичная летальность |         процент          | 38,7  | 36,2  |  35   |  34   | 33,5  | 32,5  | 31,5  |  31   |  30   |  28   |
|        | больных со               |                          |       |       |       |       |       |       |       |       |       |       |
|        | злокачественными         |                          |       |       |       |       |       |       |       |       |       |       |
|        | новообразованиями        |                          |       |       |       |       |       |       |       |       |       |       |
+--------+--------------------------+--------------------------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+
| 2.13.  | Доля выездов бригад      |         процент          |  97   |  97   |  91   | 91,5  | 91,5  | 91,7  | 91,9  |  92   |  92   |  92   |
|        | скорой медицинской       |                          |       |       |       |       |       |       |       |       |       |       |
|        | помощи со временем       |                          |       |       |       |       |       |       |       |       |       |       |
|        | доезда до больного менее |                          |       |       |       |       |       |       |       |       |       |       |
|        | 20 минут                 |                          |       |       |       |       |       |       |       |       |       |       |
+--------+--------------------------+--------------------------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+
| 2.14.  | Больничная летальность   |         процент          |  3,8  |  3,1  |  2,9  |  2,8  |  2,7  |  2,6  |  2,4  |  2,2  |  2,1  |   2   |
|        | пострадавших в           |                          |       |       |       |       |       |       |       |       |       |       |
|        | результате               |                          |       |       |       |       |       |       |       |       |       |       |
|        | дорожно-тарнспортных     |                          |       |       |       |       |       |       |       |       |       |       |
|        | происшествий             |                          |       |       |       |       |       |       |       |       |       |       |
+--------+--------------------------+--------------------------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+
| 2.15.  | Доля станций переливания |         процент          |  100  |  100  |  100  |  100  |  100  |  100  |  100  |  100  |  100  |  100  |
|        | крови, обеспечивающих    |                          |       |       |       |       |       |       |       |       |       |       |
|        | современный уровень      |                          |       |       |       |       |       |       |       |       |       |       |
|        | качества и безопасности  |                          |       |       |       |       |       |       |       |       |       |       |
|        | компонентов крови        |                          |       |       |       |       |       |       |       |       |       |       |
+--------+--------------------------+--------------------------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+
|            Подпрограмма 3. Развитие государственно-частного партнерства (индикаторы, определяются субъектом Российской Федерации)             
+-----------------------------------------------------------------------------------------------------------------------------------------------
|                                               Подпрограмма 4. Охрана здоровья матери и ребенка                                                
+--------+--------------------------+--------------------------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+
|  4.1.  | Доля обследованных       |         процент          |  20   |  25   |  35   |  40   |  45   |  50   |  50   |  55   |  60   |  77   |
|        | беременных женщин по     |                          |       |       |       |       |       |       |       |       |       |       |
|        | родовому алгоритму       |                          |       |       |       |       |       |       |       |       |       |       |
|        | проведения комплексной   |                          |       |       |       |       |       |       |       |       |       |       |
|        | пренатальной (дородовой) |                          |       |       |       |       |       |       |       |       |       |       |
|        | диагностики, нарушении   |                          |       |       |       |       |       |       |       |       |       |       |
|        | развития ребенка от      |                          |       |       |       |       |       |       |       |       |       |       |
|        | числа поставленных на    |                          |       |       |       |       |       |       |       |       |       |       |
|        | учет в первый триместр   |                          |       |       |       |       |       |       |       |       |       |       |
|        | беременности             |                          |       |       |       |       |       |       |       |       |       |       |
+--------+--------------------------+--------------------------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+
|  4.2.  | Охват неонатальным       |      Доля (процент)      |  98   | 98,5  |  99   |  99   |  99   |  99   |  99   |  99   |  99   |  99   |
|        | скринингом               |      новорожденных,      |       |       |       |       |       |       |       |       |       |       |
|        |                          |     обследованных на     |       |       |       |       |       |       |       |       |       |       |
|        |                          |      наследственные      |       |       |       |       |       |       |       |       |       |       |
|        |                          |  заболевания, от общего  |       |       |       |       |       |       |       |       |       |       |
|        |                          |   числа новорожденных    |       |       |       |       |       |       |       |       |       |       |
+--------+--------------------------+--------------------------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+
|  4.3.  | Охват                    |      Доля (процент)      | 76,5  | 92,7  |  95   |  99   |  99   |  99   |  99   |  99   |  99   |  99   |
|        | аудиологическимскринигом |      новорожденных,      |       |       |       |       |       |       |       |       |       |       |
|        |                          |     обследованных на     |       |       |       |       |       |       |       |       |       |       |
|        |                          | аудиологическийскрининг, |       |       |       |       |       |       |       |       |       |       |
|        |                          |     от общего числа      |       |       |       |       |       |       |       |       |       |       |
|        |                          |      новорожденных       |       |       |       |       |       |       |       |       |       |       |
+--------+--------------------------+--------------------------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+
|        |                          |                          |       |       |       |       |       |       |       |       |       |       |
+--------+--------------------------+--------------------------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+
|  4.4.  | Показатель ранней        |     Случаев на 1000      |  2,7  |  4,1  |   4   |  3,5  |   3   |  2,5  |  2,5  |   2   |  1,5  |   1   |
|        | неонатальной смертности  |    родившихся живыми     |       |       |       |       |       |       |       |       |       |       |
+--------+--------------------------+--------------------------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+
|  4.5.  | Смертность детей 0-17    |     Случаев на 10000     | 11,7  |  11   | 11,1  |  11   | 10,5  |  10   |  9,5  |  8,5  |   8   |  7,5  |
|        | лет                      |        населения         |       |       |       |       |       |       |       |       |       |       |
|        |                          |     соответствующего     |       |       |       |       |       |       |       |       |       |       |
|        |                          |         возраста         |       |       |       |       |       |       |       |       |       |       |
+--------+--------------------------+--------------------------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+
|  4.6.  | Доля женщин с            | Доля (процент) женщин с  | 13,9  | 12,2  |  13   |  14   |  15   |  16   |  16   |  17   |  18   |  19   |
|        | преждевременными родами, | преждевременными родами, |       |       |       |       |       |       |       |       |       |       |
|        | родоразрешенных в        |       которые были       |       |       |       |       |       |       |       |       |       |       |
|        | перинатальных центрах    |     родоразрешены в      |       |       |       |       |       |       |       |       |       |       |
|        |                          |  перинатальных центрах   |       |       |       |       |       |       |       |       |       |       |
+--------+--------------------------+--------------------------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+
|  4.7.  | Выживаемость детей,      |   Доля (+)выживших от    |   х   |  500  |  500  |  550  |  600  |  650  |  650  |  700  |  750  |  800  |
|        | имевших при рождении     |   числа новорожденных,   |       |       |       |       |       |       |       |       |       |       |
|        | очень низкую и           |   родившихся с низкой    |       |       |       |       |       |       |       |       |       |       |
|        | экстремально низкую      | массой тела в акушерском |       |       |       |       |       |       |       |       |       |       |
|        | массу тела в акушерском  |        стационаре        |       |       |       |       |       |       |       |       |       |       |
|        | стационаре               |                          |       |       |       |       |       |       |       |       |       |       |
+--------+--------------------------+--------------------------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+
|  4.8.  | Больничная летальность   |  Доля (процент) умерших  | 12,7  | 11,5  |  10   |   9   |   8   |   7   |   7   |   6   |   5   |  4,5  |
|        | детей                    |      детей от числа      |       |       |       |       |       |       |       |       |       |       |
|        |                          |       поступивших        |       |       |       |       |       |       |       |       |       |       |
+--------+--------------------------+--------------------------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+
|  4.9.  | Первичная инвалидность   |   Число детей, впервые   | 27,8  | 27,6  | 27,4  | 27,2  |  27   |  26   |  26   |  25   |  24   | 23,5  |
|        | детей                    | установлена инвалидность |       |       |       |       |       |       |       |       |       |       |
|        |                          |     (на 10 тыс.детей     |       |       |       |       |       |       |       |       |       |       |
|        |                          |     соответствующего     |       |       |       |       |       |       |       |       |       |       |
|        |                          |        возраста)         |       |       |       |       |       |       |       |       |       |       |
+--------+--------------------------+--------------------------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+
| 4.10.  | Результативность         |  Доля (процент) женщин   |  15   |  19   |  25   |  30   |  40   |  50   |  50   |  55   |  60   |  70   |
|        | мероприятий по           |    принявших решение     |       |       |       |       |       |       |       |       |       |       |
|        | профилактике абортов     | вынашивать беременность  |       |       |       |       |       |       |       |       |       |       |
|        |                          |     от числа женщин,     |       |       |       |       |       |       |       |       |       |       |
|        |                          |      обратившихся в      |       |       |       |       |       |       |       |       |       |       |
|        |                          | медицинские организации  |       |       |       |       |       |       |       |       |       |       |
|        |                          |   по поводу прерывания   |       |       |       |       |       |       |       |       |       |       |
|        |                          |       беременности       |       |       |       |       |       |       |       |       |       |       |
+--------+--------------------------+--------------------------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+
| 4.11.  | Охват пар «мать-дитя»    |         процент          | 0,01  | 0,01  | 0,01  | 0,01  | 0,01  | 0,01  | 0,01  | 0,01  | 0,01  | 0,01  |
|        | химиопрофилактикой в     |                          |       |       |       |       |       |       |       |       |       |       |
|        | соответствии со          |                          |       |       |       |       |       |       |       |       |       |       |
|        | стандартами              |                          |       |       |       |       |       |       |       |       |       |       |
+--------+--------------------------+--------------------------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+
|                     Подпрограмма 5. Развитие медицинской реабилитации и санаторно-курортного лечения, в том числе детям                       
+--------+--------------------------+--------------------------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+
|  5.1.  | Охват санатрно-курортным |         Процент          |  65   |  70   |  75   |  80   |  85   |  90   |  91   |  93   |  95   |  96   |
|        | лечением пациентов       |                          |       |       |       |       |       |       |       |       |       |       |
+--------+--------------------------+--------------------------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+
|  5.2.  | Охват реабилитационной   |         Процент          |  35   |  45   |  50   |  55   |  60   |  65   |  70   |  75   |  80   |  85   |
|        | медицинской помощью      |                          |       |       |       |       |       |       |       |       |       |       |
|        | пациентов                |                          |       |       |       |       |       |       |       |       |       |       |
+--------+--------------------------+--------------------------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+
|  5.3.  | Охват реабилитационной   |         процент          | 10,1  |  12   |  20   |  25   |  30   |  40   |  50   |  60   |  70   |  85   |
|        | медицинской помощью      |                          |       |       |       |       |       |       |       |       |       |       |
|        | детей-инвалидов от числа |                          |       |       |       |       |       |       |       |       |       |       |
|        | нуждающихся              |                          |       |       |       |       |       |       |       |       |       |       |
+--------+--------------------------+--------------------------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+
|                                       Подпрограмма 6. Оказание паллиативной помощи, в том числе детям                                         
+--------+--------------------------+--------------------------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+
|  6.1.  | Обеспеченность           |  Коек/100 тыс.взрослого  |   0   |   0   |  2,5  |  2,5  |  2,5  |   5   |   5   |   5   |   5   |   5   |
|        | паллиативными койками    |        населения         |       |       |       |       |       |       |       |       |       |       |
|        | для оказания             |                          |       |       |       |       |       |       |       |       |       |       |
|        | паллиативной помощи      |                          |       |       |       |       |       |       |       |       |       |       |
|        | взрослым                 |                          |       |       |       |       |       |       |       |       |       |       |
+--------+--------------------------+--------------------------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+
|  6.2.  | Обеспеченность           |  Коек/100 тыс.детского   |   0   |  3,7  |  3,7  |  3,7  |  3,7  |  3,7  |  3,7  |  3,7  |  3,7  |  3,7  |
|        | паллиативными койками    |        населения         |       |       |       |       |       |       |       |       |       |       |
|        | для оказания             |                          |       |       |       |       |       |       |       |       |       |       |
|        | паллиативной помощи      |                          |       |       |       |       |       |       |       |       |       |       |
|        | детям                    |                          |       |       |       |       |       |       |       |       |       |       |
+--------+--------------------------+--------------------------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+
|                                         Подпрограмма 7. Кадровое обеспечение системы здравоохранения                                          
+--------+--------------------------+--------------------------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+
|  7.1.  | Количество               |           Чел.           |  542  |  485  |  300  |  300  |  300  |  300  |  300  |  300  |  300  |  300  |
|        | подготовленных           |                          |       |       |       |       |       |       |       |       |       |       |
|        | специалистов по          |                          |       |       |       |       |       |       |       |       |       |       |
|        | программе                |                          |       |       |       |       |       |       |       |       |       |       |
|        | дополнительного          |                          |       |       |       |       |       |       |       |       |       |       |
|        | медицинского и           |                          |       |       |       |       |       |       |       |       |       |       |
|        | фармацевтического        |                          |       |       |       |       |       |       |       |       |       |       |
|        | образования в            |                          |       |       |       |       |       |       |       |       |       |       |
|        | образовательных          |                          |       |       |       |       |       |       |       |       |       |       |
|        | учреждениях              |                          |       |       |       |       |       |       |       |       |       |       |
|        | дополнительного          |                          |       |       |       |       |       |       |       |       |       |       |
|        | профессионального        |                          |       |       |       |       |       |       |       |       |       |       |
|        | образования              |                          |       |       |       |       |       |       |       |       |       |       |
+--------+--------------------------+--------------------------+-------+-------+-------+-------+-------+-------+-------+-------+-------+-------+
|  7.2.  | Количество               |           Чел.           |  93   |  102  |  149  |  100  |  100  |  100  |  100  |  100  |  100  |  100  |